Pediatric-Type Diffuse High-Grade Glioma

Pediatric-Type Diffuse High-Grade Glioma — Trials · CancerIndex

Clinical trials

Registered studies

38 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 18
Ph III recruiting: 1
Growth YoY: —
Industry share: 19%
Top sponsor: Institute of Cancer Research, United Kingdom
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (6)

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04870944	CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma	recruiting	Phase 1 / Phase 2	63	Children's Oncology GroupNETWORK	2	Sep 11, 2026	clinicaltrials
NCT06161974	Study of Olutasidenib and Temozolomide in HGG	recruiting	Phase 2	60	Rigel PharmaceuticalsINDUSTRY	7	Sep 1, 2026	clinicaltrials
NCT05009992